Inventor · disambiguated record
Hyeong Wook Choi
Also filed as: CHOI HYEONG · CHOI HYEONG-WOOK
37 granted patents·12 pending applications·146 citations·filing 2004–2025
97Inventor score
Files withEISAI R&D MAN CO LTD29EPIZYME INC10KOLMAR KOREA CO LTD3LG LIFE SCIENCES LTD3OTSUKA PHARMA CO LTD3
Top patents by PatentIndex Score
49 records- 0197US11491163B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2020·Granted Nov 8, 2022·6 cites·10 claims
- 0297US10221189B2Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin BEISAI R&D MAN CO LTD·Filed 2017·Granted Mar 5, 2019·10 cites·22 claims
- 0397US9783549B2Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin BEISAI R&D MAN CO LTD·Filed 2014·Granted Oct 10, 2017·16 cites·32 claims
- 0497US9394283B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2013·Granted Jul 19, 2016·27 cites·25 claims
- 0596US9872862B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2016·Granted Jan 23, 2018·14 cites·17 claims
- 0695US10821113B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2019·Granted Nov 3, 2020·6 cites·20 claims
- 0795US10611773B2Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin BEISAI R&D MAN CO LTD·Filed 2019·Granted Apr 7, 2020·5 cites·17 claims
- 0895US10308661B2Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolidesEISAI R&D MAN CO LTD·Filed 2016·Granted Jun 4, 2019·9 cites·26 claims
- 0994US10710987B2Hydrochloride salt form for EZH2 inhibitionEPIZYME INC·Filed 2018·Granted Jul 14, 2020·8 cites·25 claims
- 1092US10245269B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2017·Granted Apr 2, 2019·8 cites·18 claims
- 1191US10934307B2Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin BEISAI R&D MAN CO LTD·Filed 2020·Granted Mar 2, 2021·2 cites·10 claims
- 1290US10040782B2Hydrochloride salt form for EZH2 inhibitionEPIZYME INC·Filed 2014·Granted Aug 7, 2018·12 cites·14 claims
- 1387US10246480B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Granted Apr 2, 2019·5 cites·30 claims
- 1487US9834576B2Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridinesOTSUKA PHARMA CO LTD·Filed 2014·Granted Dec 5, 2017·7 cites·28 claims
- 1586US10836784B2Substituted phosphorodiamidate morpholino oligomersEISAI R&D MAN CO LTD·Filed 2019·Granted Nov 17, 2020·2 cites·6 claims
- 1686US10457698B2Chiral reagents for preparation of substituted phosphorodiamidate morpholino oligomersEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 29, 2019·4 cites·4 claims
- 1783US12251386B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2022·Granted Mar 18, 2025·0 cites·35 claims
- 1882US2025171475A1Chiral reagents for preparation of homogeneous oligomersEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 1978US2025268905A1Salt form of a human histone methyltransferase ezh2 inhibitorEPIZYME INC·Filed 2025·Application pending·0 cites
- 2077US8044080B2Isoxazoline derivative and novel process for its preparationLG LIFE SCIENCES LTD·Filed 2006·Granted Oct 25, 2011·3 cites·19 claims
- 2176US10526362B2Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridinesOTSUKA PHARMA CO LTD·Filed 2017·Granted Jan 7, 2020·1 cites·13 claims
- 2274US11643418B2Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin BEISAI R&D MAN CO LTD·Filed 2021·Granted May 9, 2023·0 cites·5 claims
- 2372US2023151022A1Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereofEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 2470US11028119B2Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridinesOTSUKA PHARMA CO LTD·Filed 2019·Granted Jun 8, 2021·0 cites·12 claims
- 2569US11339188B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2020·Granted May 24, 2022·0 cites·18 claims
- 2669US10793581B2Stereochemically defined polypropionates and methods for making and using the sameEISAI R&D MAN CO LTD·Filed 2019·Granted Oct 6, 2020·0 cites·19 claims
- 2768US12280135B2Cosmetic composition for peel-off-type packs, and method for producing sameKOLMAR KOREA CO LTD·Filed 2022·Granted Apr 22, 2025·0 cites·2 claims
- 2867US11434246B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2021·Granted Sep 6, 2022·0 cites·30 claims
- 2967US2021171555A1Chiral reagents for preparation of homogeneous oligomersEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 3066US10941148B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 9, 2021·0 cites·22 claims
- 3166US10913749B2Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolidesEISAI R&D MAN CO LTD·Filed 2019·Granted Feb 9, 2021·0 cites·21 claims
- 3266US10407439B2Stereochemically defined polypropionates and methods for making and using the sameEISAI R&D MAN CO LTD·Filed 2018·Granted Sep 10, 2019·0 cites·8 claims
- 3365US2021017163A1Hydrochloride salt form for ezh2 inhibitionEPIZYME INC·Filed 2020·Application pending·0 cites
- 3464US11242366B2Microcapsule including peptide having cell receptor binding affinity and cosmetic composition containing sameKOLMAR KOREA CO LTD·Filed 2018·Granted Feb 8, 2022·0 cites·16 claims
- 3563US2025163095A1Bis-protected, activated guanine monomersEISAI R&D MAN CO LTD·Filed 2023·Application pending·0 cites
- 3662US11542269B2Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereofEISAI R&D MAN CO LTD·Filed 2019·Granted Jan 3, 2023·0 cites·7 claims
- 3762US10618930B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2019·Granted Apr 14, 2020·0 cites·18 claims
- 3861US2025092392A1Antisense oligonucleotides and their use for treatment of neurodegenerative disordersEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 3960US2025346624A1Polynucleotide and producing method thereofEISAI R&D MAN CO LTD·Filed 2025·Application pending·0 cites
- 4059US10316040B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2016·Granted Jun 11, 2019·0 cites·20 claims
- 4159US10160768B2Stereochemically defined polypropionates and methods for making and using the sameEISAI R&D MAN CO LTD·Filed 2015·Granted Dec 25, 2018·0 cites·6 claims
- 4258US7557133B2Caspase inhibitors containing isoxazoline ringLG LIFE SCIENCES LTD·Filed 2004·Granted Jul 7, 2009·1 cites·21 claims
- 4358US2020055883A1Cyclic di-nucleotides derivative for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 4455US2024060068A1Poly-morpholino oligonucleotide gapmersFANG FRANCIS G·Filed 2021·Application pending·0 cites
- 4554US12251394B2Methods for the treatment of bladder cancerEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 18, 2025·0 cites·12 claims
- 4654US2022195437A1Tau-targeting oligonucleotide gapmersEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 4751US2019000742A1Cosmetic composition for peel-off-type packs, and method for producing sameKOLMAR KOREA CO LTD·Filed 2016·Application pending·0 cites
- 4849US7906676B2Process for preparing 3-amino-5-fluoro-4-dialkoxypentanoic acid esterLG LIFE SCIENCES LTD·Filed 2007·Granted Mar 15, 2011·0 cites·18 claims
- 4942US11136335B2Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereofEISAI R&D MAN CO LTD·Filed 2017·Granted Oct 5, 2021·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →